Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
Clinical trial NCT03186209 · COMPLETED
Trial details
- NCT number
- NCT03186209
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-07
- Primary completion
- 2023-01-30
- Enrollment
- 695
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.